HAE: Clinical Trials

1 trial for HAE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow HAE: new trials by email Literature Review of HAE trials Research Report on HAE

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-label, Long-term Safety Study of Avoralstat in Subjects With Hereditary Angioedema
avoralstat - Hereditary Angioedema, HAE
Phase 3TerminatedBioCryst Pharmaceuticals62015-12-012016-02-17

Narrower conditions

Angioedemas, Hereditary (1)

Broader conditions

Angioedema (1)  ·  Cardiovascular Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hereditary Complement Deficiency Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Primary Immunodeficiency Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Urticaria (1)  ·  Vascular Diseases (1)

Interventions

avoralstat (1)

Sponsors

BioCryst Pharmaceuticals (1)

Countries

Belgium (1)  ·  France (1)

Top investigators

Henriette Farkas, MD, PhD, DSc (1)